IBDEI0BM ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15482,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,15482,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,15482,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,15483,0)
 ;;=257.2^^98^871^37
 ;;^UTILITY(U,$J,358.3,15483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15483,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,15483,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,15483,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,15484,0)
 ;;=253.2^^98^871^41
 ;;^UTILITY(U,$J,358.3,15484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15484,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,15484,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,15484,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,15485,0)
 ;;=733.00^^98^871^52
 ;;^UTILITY(U,$J,358.3,15485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15485,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,15485,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,15485,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,15486,0)
 ;;=278.00^^98^871^48
 ;;^UTILITY(U,$J,358.3,15486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15486,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,15486,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,15486,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,15487,0)
 ;;=278.01^^98^871^47
 ;;^UTILITY(U,$J,358.3,15487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15487,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,15487,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,15487,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,15488,0)
 ;;=250.80^^98^871^15
 ;;^UTILITY(U,$J,358.3,15488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15488,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,15488,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,15488,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,15489,0)
 ;;=250.00^^98^871^9
 ;;^UTILITY(U,$J,358.3,15489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15489,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,15489,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,15489,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,15490,0)
 ;;=250.40^^98^871^11
 ;;^UTILITY(U,$J,358.3,15490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15490,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,15490,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,15490,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,15491,0)
 ;;=250.50^^98^871^14
 ;;^UTILITY(U,$J,358.3,15491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15491,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,15491,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,15491,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,15492,0)
 ;;=250.60^^98^871^12
 ;;^UTILITY(U,$J,358.3,15492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15492,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,15492,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,15492,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,15493,0)
 ;;=250.70^^98^871^13
 ;;^UTILITY(U,$J,358.3,15493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15493,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,15493,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,15493,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,15494,0)
 ;;=250.01^^98^871^8
 ;;^UTILITY(U,$J,358.3,15494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15494,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,15494,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,15494,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,15495,0)
 ;;=272.0^^98^871^28
 ;;^UTILITY(U,$J,358.3,15495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15495,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,15495,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,15495,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,15496,0)
 ;;=272.1^^98^871^33
 ;;^UTILITY(U,$J,358.3,15496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15496,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,15496,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,15496,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,15497,0)
 ;;=272.2^^98^871^30
 ;;^UTILITY(U,$J,358.3,15497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15497,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,15497,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,15497,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15498,0)
 ;;=275.42^^98^871^27
 ;;^UTILITY(U,$J,358.3,15498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15498,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,15498,1,5,0)
 ;;=5^Hypercalcaemia
 ;;^UTILITY(U,$J,358.3,15498,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,15499,0)
 ;;=275.41^^98^871^35
 ;;^UTILITY(U,$J,358.3,15499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15499,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,15499,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,15499,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,15500,0)
 ;;=276.7^^98^871^29
 ;;^UTILITY(U,$J,358.3,15500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15500,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,15500,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,15500,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,15501,0)
 ;;=275.2^^98^871^25
 ;;^UTILITY(U,$J,358.3,15501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15501,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,15501,1,5,0)
 ;;=5^Hyper or Hypomagnesaemia
 ;;^UTILITY(U,$J,358.3,15501,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,15502,0)
 ;;=276.0^^98^871^31
 ;;^UTILITY(U,$J,358.3,15502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15502,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,15502,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,15502,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,15503,0)
 ;;=276.1^^98^871^38
 ;;^UTILITY(U,$J,358.3,15503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15503,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,15503,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,15503,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,15504,0)
 ;;=275.3^^98^871^26
 ;;^UTILITY(U,$J,358.3,15504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15504,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,15504,1,5,0)
 ;;=5^Hyper or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,15504,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,15505,0)
 ;;=240.0^^98^871^20
 ;;^UTILITY(U,$J,358.3,15505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15505,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,15505,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,15505,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,15506,0)
 ;;=241.1^^98^871^19
 ;;^UTILITY(U,$J,358.3,15506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15506,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,15506,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,15506,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,15507,0)
 ;;=241.0^^98^871^59
 ;;^UTILITY(U,$J,358.3,15507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15507,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,15507,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,15507,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,15508,0)
 ;;=242.00^^98^871^21
 ;;^UTILITY(U,$J,358.3,15508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15508,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,15508,1,5,0)
 ;;=5^Graves' Disease
 ;;^UTILITY(U,$J,358.3,15508,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,15509,0)
 ;;=242.01^^98^871^18
 ;;^UTILITY(U,$J,358.3,15509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15509,1,4,0)
 ;;=4^242.01
 ;;^UTILITY(U,$J,358.3,15509,1,5,0)
 ;;=5^Goiter Diff Tox W Strm
 ;;^UTILITY(U,$J,358.3,15509,2)
 ;;=^267794
 ;;^UTILITY(U,$J,358.3,15510,0)
 ;;=252.1^^98^871^40
 ;;^UTILITY(U,$J,358.3,15510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15510,1,4,0)
 ;;=4^252.1
 ;;^UTILITY(U,$J,358.3,15510,1,5,0)
 ;;=5^Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,15510,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,15511,0)
 ;;=242.90^^98^871^32
 ;;^UTILITY(U,$J,358.3,15511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15511,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,15511,1,5,0)
 ;;=5^Hyperthyroid W/O Goiter Or Strm
 ;;^UTILITY(U,$J,358.3,15511,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,15512,0)
 ;;=242.91^^98^871^45
 ;;^UTILITY(U,$J,358.3,15512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15512,1,4,0)
 ;;=4^242.91
 ;;^UTILITY(U,$J,358.3,15512,1,5,0)
 ;;=5^Hyprthy W/O Goit W Strm
 ;;^UTILITY(U,$J,358.3,15512,2)
 ;;=^267812
 ;;^UTILITY(U,$J,358.3,15513,0)
 ;;=244.0^^98^871^43
 ;;^UTILITY(U,$J,358.3,15513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15513,1,4,0)
 ;;=4^244.0
 ;;^UTILITY(U,$J,358.3,15513,1,5,0)
 ;;=5^Hypothyroid, Postsurgical
 ;;^UTILITY(U,$J,358.3,15513,2)
 ;;=^267814
 ;;^UTILITY(U,$J,358.3,15514,0)
 ;;=244.2^^98^871^42
 ;;^UTILITY(U,$J,358.3,15514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15514,1,4,0)
 ;;=4^244.2
 ;;^UTILITY(U,$J,358.3,15514,1,5,0)
 ;;=5^Hypothyroid Due To Iodine Rx
 ;;^UTILITY(U,$J,358.3,15514,2)
 ;;=^267817
 ;;^UTILITY(U,$J,358.3,15515,0)
 ;;=244.9^^98^871^44
 ;;^UTILITY(U,$J,358.3,15515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15515,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,15515,1,5,0)
 ;;=5^Hypothyroid, Unspec Cause
 ;;^UTILITY(U,$J,358.3,15515,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,15516,0)
 ;;=245.0^^98^871^60
 ;;^UTILITY(U,$J,358.3,15516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15516,1,4,0)
 ;;=4^245.0
 ;;^UTILITY(U,$J,358.3,15516,1,5,0)
 ;;=5^Thyroiditis, Acute
 ;;^UTILITY(U,$J,358.3,15516,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,15517,0)
 ;;=245.1^^98^871^61
 ;;^UTILITY(U,$J,358.3,15517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15517,1,4,0)
 ;;=4^245.1
 ;;^UTILITY(U,$J,358.3,15517,1,5,0)
 ;;=5^Thyroiditis, Subacute
 ;;^UTILITY(U,$J,358.3,15517,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,15518,0)
 ;;=733.01^^98^871^54
 ;;^UTILITY(U,$J,358.3,15518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15518,1,4,0)
 ;;=4^733.01
 ;;^UTILITY(U,$J,358.3,15518,1,5,0)
 ;;=5^Osteoporosis, Senile
 ;;^UTILITY(U,$J,358.3,15518,2)
 ;;=Osteoporosis, Senile^87188
 ;;^UTILITY(U,$J,358.3,15519,0)
 ;;=733.02^^98^871^53
